×
News

Advertising and Promotion Update - Drugs, Devices and Combination Products

November 20, 2015
By Abeba Habtemariam Abraham Gitterman

Vernessa Pollard, Abeba Habtemariam, and Abraham Gitterman will be presenting "Advertising and Promotion Update - Drugs, Devices and Combination Products" on Friday, November 20 from 10:30 a.m. to 11:30 a.m.  This CLE program will cover legal trends and current developments in the advertisement and promotion of prescription drugs and medical devices.  To RSVP for this teleconference, please contact Emilie Lawson at 202.942.6712. 

Find more content tagged:

Stay up-to-date with the latest topics from the firm.

Email Subscriptions RSS Feed (All Perspectives) RSS Feed (News Only)

Meet the speakers

Abeba Habtemariam
Abeba Habtemariam
Senior Associate
Arnold & Porter
abeba.habtemariam@arnoldporter.com
VCard
Abraham Gitterman
Abraham Gitterman
Associate
Arnold & Porter
abraham.gitterman@arnoldporter.com
VCard

Related Articles

January 31, 2019
2019 Regulatory Boot Camp
Arnold & Porter's Future Pharma Forum, London, United Kingdom
November 22, 2018
Contract Law for Life Sciences Lawyers
November 13, 2018
Competition Law in Life Sciences Seminar
Zürich
October 4, 2018
Life Science Transactions: Getting to a Successful Deal
Cambridge
September 27, 2018
Implications of Recent EU and UK Court Decisions in the Pharmaceutical Sector
London
July 16, 2018
Examining FDA's Final Guidance Documents on Medical Product Communications to Payors and Communications Consistent with Approved Labeling
Webinar
May 10, 2018
Looming EU GDPR Requirements: What Life Sciences Companies Must Do to Ensure Compliance
Arnold & Porter Webinar
April 18, 2018
Inaugural US Future Pharma Forum
Short Hills
February 22, 2018
EU Medical Devices Bootcamp
London
January 18, 2018
Life Sciences Legal Update Conference
London
Practical Guide to the New EU Medical Devices Framework: Are You Prepared?
Wednesday, April 19, 2017
Payor Interactions: Emerging Risks and Compliance Considerations
Webinar
Thursday, February 9,2017
Corporate & Commercial 101 - Business Development Briefing: What you need to know when working on corporate and commercial transactions
London
December 13, 2016
21st Century Cures Act: What Life Sciences Companies Need To Know
Arnold & Porter Webinar
Friday, July 22, 2016
Compliance with Final PAMA Rules - Advanced Diagnostic Laboratory Tests: What Considerations for Launching a New Test?
Webinar
Tuesday, July 12, 2016
Compliance with Final PAMA Rules - Private Payor Data Reporting: What Information Must Be Reported, When, and How?
Webinar
Monday, June 27, 2016
Compliance with Final PAMA Rules - Applicable Laboratories: Is Your Lab Required to Report?
Webinar
Thursday, June 16, 2016
How Effective Is Your Compliance Program?
Webinar
Tuesday, June 14, 2016
Pharmaceutical and Medical Device Enforcement and Investigations Forum
Morristown
Tuesday, April 19, 2016
Staying Ahead of the Curve: Managing Advertising and Data Privacy and Security Issues Raised by Consumer-Directed Mobile Apps and Health IT
Webinar
Tuesday, April 5, 2016
Olympus’ $640 Million Fraud & Abuse and FCPA Settlement: What It Means for Your Global Compliance Program
Webinar
Thursday, February 11, 2016
Hot Global Compliance Topics in the Pharmaceutical and Medical Device Sectors: Controlling Evolving Risks
Webinar
December 2, 2015
Arnold & Porter's Life Sciences Legal Update Conference
London
December 1, 2015
Pharmaceutical and Medical Device Compliance Update: Management of Critical and Emerging Legal Challenges
Morristown
November 3, 2015
Are You Ready?: Preparing for a New Joint Venture, Partnership, or Sale Transaction
October 28, 2015
Managing Litigation and Compliance Risks: Are mHealth and Health IT the New Frontier for Product Liability and Enforcement?
Arnold & Porter Webinar
October 13, 2015
Finding the Right Partner and Model: Joint Ventures, Integration, and Outsourcing Strategies to Meet Today's Healthcare Payment and Delivery Challenges
October 6, 2015
New Payment Rate Reporting Requirements for Clinical Laboratories: Are You Prepared?
October 1, 2015
How is Medicare Adapting to the mHealth and Emerging Technologies Revolution?
July 20, 2015
It's Getting Hot in Here: Sunshine Act Reporting Trends, Enforcement, and Best Practices
June 16, 2015
Getting Your House in Order: Key Compliance and Corporate Issues that Diminish Value or Kill the Deal
June 10, 2015
Connecting Through mHealth Solutions: Fraud & Abuse Implications for Patient, Physician, ACO, Hospital and Industry Partner Engagement Models
May 27, 2015
Physician Compensation in the 21st Century / Demand for Medical Technology
May 19, 2015
Physician Compensation in the 21st Century / Physician Leadership
May 18, 2015
Medicare's New Physician Payment System: What's Now, and What's Next
April 30, 2015
Arnold & Porter US and EU Drug and Device Enforcement Boot Camp
Summit
April 16, 2015
Understanding NICE and Health Technology Appraisals
March 24, 2015
Beyond Product Launch: Navigating FDA Post-Market Requirements for mHealth and Health IT
February 19, 2015
Use of Investigative Resources and Assertion of Victim Rights To Support Brand Protection
January 27-28, 2015
FCPA Boot Camp
December 11, 2014
Drug Supply Chain Security Act (DSCSA): How To Get Ready (Fast) for Track & Trace
December 3, 2014
Emerging Issues in FDA Law: Implementation of DQSA
November 20, 2014
FDA Medical Device Law Fundamentals
October 16, 2014 - October 17, 2014
Arnold & Porter's Life Sciences Legal Update Day
London
September 9, 2014
European Compliance Update
May 13, 2014
Hospital Qui Tam Symposium: Preventing Whistleblower Suits Through the Coordination of Employment and False Claims Counsel
February 20, 2014
Trends and Hot Topics Concerning Pharmaceutical Industry Risk Enforcement
February 5, 2014
European Life Sciences Legal Update Day
Washington
December 16, 2013
Breakthrough or More of the Same? New Pathways and Exclusivities in FDA Approval Processes
December 10, 2013
The FDA's Upcoming Trans Fat Ban: Prelude to More Food Industry Litigation?
December 6, 2013
Upcoming CLE Course: Critical Issues in Pharmaceutical Promotion and Medical Affairs Activities
Princeton
September 25, 2013
Upcoming CLE Course: Enforcement Trends Update
April 17, 2013
Emerging Issues in Food and Drug Law: Implementation of FDASIA
Washington
March 5, 2013
Developments in the 340B Program - Legal and Strategic Perspectives on Program Integrity, Manufacturer Audits, and the Determination of "Reasonable Cause" for an Audit
February 28, 2013
Good Day, Sunshine: Key Components and Implications of the Final Rule Implementing the Physician Payment Sunshine Act
January 31, 2013
IP/Technology 2013 Update: Trademark, Copyright, Trade Secret, and Unfair Competition Program
January 30, 2013
IP/Technology 2013 Update: Patent Law Program
November 16, 2012
Hot Topics for Drug Manufacturers: Orphan Drugs, FDASIA, Clinical Studies, and Warning Letter Trends
Wilmington
November 16, 2011
Emergency ACO Summit: Analyzing the Final Rule
New York
May 17, 2011
Current Issues in the Cosmetics Sector and Future Trends
London
January 11, 2011
The Arnold & Porter Knowledge Leader Series: Pharmaceuticals: Key Trends and Regulatory Developments in 2010-The Prospects for 2011
December 1, 2010
WEBCAST: Marketing Medical and Consumer Products in Social Media
September 27-28, 2010
Government Investigations for Life Sciences
September 15, 2010
Protecting Your Medical Products Supply Chain: A Webinar on Preventing and Addressing Cargo/Warehouse Theft
August 10, 2010
Strategies for Successful Hospital-Physician Alignment: What Physicians and Hospitals Need to Know
New York
July 27, 2010
False Claims Act and Anti-Kickback Statute Enforcement on Performance Based Contracts in the Pharmaceutical and Device Industries
June 3, 2010
Brand Integrity, Security, and Anti-Counterfeiting for the Pharmaceutical Industry How to Deal With the Bad Guys and Work with the Feds
May 25, 2010
American Conference Institute's FDA Enforcement Summit
May 13, 2010
New York Society for Health Planning presents UPDATE - New York State/Federal Payment Recovery Agenda Understanding and Successfully Navigating the Risks
New York
May 5, 2010
BIO International Convention - Legal/Intellectual Property
May 5, 2010
BIO International Convention - Impact on Policy in Biobusiness
April 26, 2010
Health Care 2010: Managing Risks in the New Compliance and Enforcement Environment
April 15, 2010
8th Corporate Counsel Expert Guide to Advertising, eMarketing & Promotions for the Pharmaceutical Industry
March 24, 2010 - March 25, 2010
FDA Boot Camp
November 11, 2009 - November 13, 2009
Introduction and Overview: Challenges for the Pharmaceutical Industry in Internet and Social Marketing Activities
October 19, 2009 - October 21, 2009
Conference on 5th Annual Biosimilars (Conference and Workshop)
London
September 22, 2009 - September 24, 2009
Medical Technology Reimbursement Professionals Workshop
Washington
May 28, 2009
The International Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum
Rome
May 14, 2009 - May 15, 2009
Drug and Medical Device Seminar
New York
April 3, 2009
The Food, Drug and Cosmetic Act: Searching for the Crossroads of Safety and Innovation
Saint Paul
March 25, 2009 - March 26, 2009
Molecular Diagnostics and the Changing Landscape--From Development through Reimbursement: Considerations and Implications
Washington
March 18, 2009
Nuts and Bolts of Sustaining Programs Through Mergers & Collaborations
New York
March 16, 2009, 12:15 p.m. ET
Medicare 101
March 5, 2009 - March 6, 2009
First Annual Summit on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies
Washington
February 24, 2009 - February 25, 2009
11th National Conference on Managing Legal Risks in Structuring & Conducting Clinical Trials
New York
February 15, 2009
PODCAST: Medical Practice Trends Podcast 5: Washington Update: Relationships between MDs and Pharma Scrutinized
January 13, 2009
Pharmaceutical Risk Management: Practical Applications
Washington
December 2, 2008 - December 3, 2008
ECRI Institute's 16th Annual Conference on Using Evidence in Policy and in Practice
Washington
November 17, 2008 - November 18, 2008
American Conference Institute's 7th Annual Corporate Counsel Forum on Advertising & Promotions for the Pharmaceutical Industry
New York
May 7, 2008 - May 9, 2008
10th Annual Medicaid Rebates
May 7, 2008 - May 10, 2008
Legal & Regulatory Conference 2008
Chicago
March 26, 2008 - March 28, 2008
Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress at Harvard
Cambridge
March 11, 2008 - March 13, 2008
AdvaMed 2008 Annual Meeting
La Quinta
January 28, 2008 - January 30, 2008
4th Annual In-House Counsel Forum on Pharmaceutical Antitrust
Washington
December 12, 2007 - December 14, 2007
12th Annual Drug & Medical Device Litigation, 2007
New York
November 7, 2007 - November 9, 2007
The Eighth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum
Washington
October 24, 2007 - October 25, 2007
3rd Biennial Federal Drug Pricing Program: Confronting the Complexities of Federal Drug Pricing: 15 Years of the Veterans Health Care Act
Countryside
October 22, 2007
CLE: The FDA Amendments Act: Overview and Implications for Pharmaceutical Manufacturers
Wilmington
October 1, 2007 - October 3, 2007
AdvaMed 2007
Washington
September 24, 2007 - September 25, 2007
Biosimilars 2007
Washington
June 20, 2007 - June 21, 2007
Medical Device Pricing & Reimbursement
Chicago
May 6, 2007 - May 9, 2007
Bio International Convention
Boston
December 5, 2006
Healthcare on the Hill
Washington
May 11, 2005 - May 11, 2005
Registries and Post-Marketing Data Collection
Washington

Email Disclaimer

Reject Accept